Solventum Corporation's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Solventum Corporation reported revenue of $8.3B (+0.9% year on year) and net income of $1.6B (+224.8% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY |
|---|---|---|
| Total net sales | $8.3B | $8.3B |
| Cost of sales | $3.9B | $3.7B |
| Gross profit | $4.5B | $4.6B |
| Selling, general and administrative expenses | $3.1B | $2.8B |
| Research and development expenses | $739.0M | $775.0M |
| Gain on sale of business | ($1.5B) | — |
| Operating income | $2.2B | $1.0B |
| Interest expense, net | $347.0M | $367.0M |
| Loss on debt extinguishment, net | $82.0M | — |
| Other expense (income), net | $39.0M | $64.0M |
| Income before income taxes | $1.7B | $605.0M |
| Provision for income taxes | $157.0M | $127.0M |
| Net income | $1.6B | $479.0M |
| Basic earnings per share (in dollars per share) | $8.94 | $2.77 |
| Diluted earnings per share (in dollars per share) | $8.88 | $2.76 |
| Basic (in shares) | 174.1M | 173.2M |
| Diluted (in shares) | 175.3M | 173.7M |
| Line item | Sep 30, 2026 · Q3 | Jun 30, 2026 · Q2 | Mar 31, 2026 · Q1 | Sep 30, 2025 · Q3 |
|---|---|---|---|---|
| Total net sales | $1.9B | $2.2B | $2.0B | $2.1B |
| Cost of sales | $887.0M | $923.0M | $911.0M | $961.0M |
| Gross profit | $1.1B | $1.3B | $1.1B | $1.1B |
| Selling, general and administrative expenses | $813.0M | $927.0M | $827.0M | $780.0M |
| Research and development expenses | $181.0M | $178.0M | $189.0M | $183.0M |
| Gain on sale of business | $0 | — | — | ($1.5B) |
| Operating income | $68.0M | $181.0M | $81.0M | $1.7B |
| Interest expense, net | $68.0M | $64.0M | $62.0M | $89.0M |
| Loss on debt extinguishment, net | $0 | — | — | $82.0M |
| Other expense (income), net | $10.0M | $9.0M | $4.0M | $5.0M |
| Income (loss) before income taxes | ($11.0M) | $108.0M | $16.0M | $1.5B |
| Provision for (benefit from) income taxes | $1.0M | $15.0M | $3.0M | $248.0M |
| Net income (loss) | ($12.0M) | $92.0M | $13.0M | $1.3B |
| Basic earnings per share (in dollars per share) | -$0.07 | $0.53 | $0.07 | $7.26 |
| Diluted earnings per share (in dollars per share) | -$0.07 | $0.53 | $0.07 | $7.22 |
| Basic (in shares) | 170.8M | 172.7M | 174.2M | 174.3M |
| Diluted (in shares) | 170.8M | 173.3M | 175.5M | 175.4M |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY |
|---|---|---|
| Cash and cash equivalents | $878.0M | $762.0M |
| Accounts receivable — net of allowances of $87 and $86 | $1.0B | $1.0B |
| Due from related parties | $150.0M | $185.0M |
| Finished goods | $636.0M | $539.0M |
| Work in process | $201.0M | $190.0M |
| Raw materials and supplies | $229.0M | $236.0M |
| Total inventories | $1.1B | $965.0M |
| Other current assets | $731.0M | $293.0M |
| Total current assets | $3.9B | $3.2B |
| Property, plant and equipment — net | $1.3B | $1.6B |
| Goodwill | $5.7B | $6.4B |
| Intangible assets — net | $2.6B | $2.5B |
| Other assets | $814.0M | $665.0M |
| Total assets | $14.3B | $14.5B |
| Short-term borrowings and current portion of long-term debt | $0 | $200.0M |
| Accounts payable | $687.0M | $618.0M |
| Due to related parties | $435.0M | $272.0M |
| Unearned revenue | $621.0M | $572.0M |
| Other current liabilities | $1.4B | $1.0B |
| Total current liabilities | $3.1B | $2.7B |
| Long-term debt | $5.0B | $7.8B |
| Pension and postretirement benefits | $363.0M | $350.0M |
| Deferred income taxes | $164.0M | $225.0M |
| Other liabilities | $547.0M | $410.0M |
| Total liabilities | $9.2B | $11.5B |
| Common stock, par value $0.01 per share, 750,000,000 shares authorized | $2000000.00 | $2000000.00 |
| Additional paid-in-capital | $3.9B | $3.8B |
| Retained earnings | $1.8B | $242.0M |
| Accumulated other comprehensive income (loss) | ($625.0M) | ($1.1B) |
| Total equity | $5.0B | $3.0B |
| Total liabilities and equity | $14.3B | $14.5B |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Sep 30, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $451.0M | $403.0M | $561.0M | $1.6B |
| Accounts receivable — net of allowances of $86 and $87 | $1.4B | $1.3B | $1.1B | $1.0B |
| Due from related parties | $27.0M | $122.0M | $121.0M | $157.0M |
| Finished goods | $613.0M | $573.0M | $643.0M | $625.0M |
| Work in process | $235.0M | $218.0M | $222.0M | $191.0M |
| Raw materials and supplies | $254.0M | $249.0M | $224.0M | $233.0M |
| Total inventories | $1.1B | $1.0B | $1.1B | $1.0B |
| Other current assets | $750.0M | $865.0M | $754.0M | $540.0M |
| Total current assets | $3.7B | $3.7B | $3.6B | $4.4B |
| Property, plant and equipment — net | $1.6B | $1.6B | $1.5B | $1.3B |
| Goodwill | $5.6B | $5.6B | $5.6B | $5.3B |
| Intangible assets — net | $2.3B | $2.4B | $2.5B | $2.2B |
| Other assets | $946.0M | $904.0M | $848.0M | $747.0M |
| Total assets | $14.2B | $14.2B | $14.1B | $14.0B |
| Short-term borrowings and current portion of long-term debt | $507.0M | $506.0M | $505.0M | $0 |
| Accounts payable | $808.0M | $701.0M | $699.0M | $669.0M |
| Due to related parties | $152.0M | $331.0M | $337.0M | $464.0M |
| Unearned revenue | $596.0M | $596.0M | $613.0M | $576.0M |
| Other current liabilities | $1.5B | $1.5B | $1.2B | $1.2B |
| Total current liabilities | $3.6B | $3.7B | $3.3B | $2.9B |
| Long-term debt | $4.6B | $4.6B | $4.6B | $5.1B |
| Pension and postretirement benefits | $355.0M | $358.0M | $360.0M | $306.0M |
| Deferred income taxes | $154.0M | $157.0M | $161.0M | $169.0M |
| Finance leases | $206.0M | $207.0M | $207.0M | — |
| Other liabilities | $508.0M | $486.0M | $478.0M | $437.0M |
| Total liabilities | $9.4B | $9.4B | $9.1B | $9.0B |
| Common stock, par value $0.01 per share, 750,000,000 shares authorized | $2000000.00 | $2000000.00 | $2000000.00 | $2000000.00 |
| Additional paid-in-capital | $4.0B | $3.9B | $3.9B | $3.9B |
| Retained earnings | $1.9B | $1.9B | $1.8B | $1.7B |
| Treasury stock, at cost | ($403.0M) | ($355.0M) | ($67.0M) | — |
| Accumulated other comprehensive income (loss) | ($667.0M) | ($669.0M) | ($670.0M) | ($604.0M) |
| Total equity | $4.8B | $4.8B | $5.0B | $5.0B |
| Total liabilities and equity | $14.2B | $14.2B | $14.1B | $14.0B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY |
|---|---|---|
| Net income | $1.6B | $479.0M |
| Depreciation and amortization | $489.0M | $555.0M |
| Pension and postretirement benefit expense | $62.0M | $34.0M |
| Stock-based compensation expense | $161.0M | $112.0M |
| Gain on sale of business | ($1.5B) | $0 |
| Transaction costs | ($111.0M) | — |
| Deferred income taxes | ($120.0M) | ($155.0M) |
| Accounts receivable | $34.0M | $43.0M |
| Due from related parties | $44.0M | $233.0M |
| Inventories | ($139.0M) | ($132.0M) |
| Accounts payable | $104.0M | $266.0M |
| Due to related parties | ($11.0M) | ($565.0M) |
| Accrued compensation | $43.0M | — |
| All other operating activities - net | ($194.0M) | $315.0M |
| Net cash provided by operating activities | $369.0M | $1.2B |
| Purchases of property, plant and equipment | ($379.0M) | ($380.0M) |
| Acquisitions, net of cash acquired | ($696.0M) | — |
| Proceeds from sale of business | $3.9B | $0 |
| Other — net | ($18.0M) | $0 |
| Net cash provided by (used in) investing activities | $2.8B | ($380.0M) |
| Repayment of debt | ($3.1B) | ($300.0M) |
| Net transfers to 3M | ($33.0M) | ($8.3B) |
| Proceeds from long-term debt, net of issuance costs | $0 | $8.3B |
| Other — net | $46.0M | $8.0M |
| Net cash used in financing activities | ($3.1B) | ($240.0M) |
| Effect of exchange rate changes on cash and cash equivalents | $7.0M | $3.0M |
| Net increase (decrease) in cash and cash equivalents | $116.0M | $568.0M |
| Cash and cash equivalents at beginning of year | $762.0M | $194.0M |
| Cash and cash equivalents at end of year | $878.0M | $762.0M |
| Income taxes | $181.0M | $244.0M |
| Interest | $442.0M | $287.0M |
| Line item | Sep 30, 2026 · YTD | Jun 30, 2026 · YTD | Mar 31, 2026 · Q1 | Sep 30, 2025 · YTD |
|---|---|---|---|---|
| Net income | $93.0M | $105.0M | $13.0M | $1.5B |
| Depreciation and amortization | $404.0M | $268.0M | $135.0M | $372.0M |
| Pension and postretirement benefits | $40.0M | $27.0M | $14.0M | $49.0M |
| Stock-based compensation expense | $131.0M | $89.0M | $51.0M | $124.0M |
| Gain on sale of business | $0 | — | — | ($1.5B) |
| Purification and Filtration transaction costs | $0 | — | — | ($86.0M) |
| Deferred income taxes | ($139.0M) | ($88.0M) | ($41.0M) | ($47.0M) |
| Accounts receivable | ($340.0M) | ($286.0M) | ($34.0M) | $36.0M |
| Due from related parties | $123.0M | $27.0M | $28.0M | $37.0M |
| Inventories | ($42.0M) | $18.0M | ($32.0M) | ($134.0M) |
| Accounts payable | $111.0M | $26.0M | $23.0M | $74.0M |
| Due to related parties | ($300.0M) | ($117.0M) | ($100.0M) | $18.0M |
| Accrued compensation | ($58.0M) | ($101.0M) | ($151.0M) | ($9.0M) |
| All other operating activities — net | $192.0M | $68.0M | ($94.0M) | ($135.0M) |
| Net cash provided by operating activities | $215.0M | $38.0M | ($189.0M) | $274.0M |
| Purchases of property, plant and equipment | ($247.0M) | ($167.0M) | ($84.0M) | ($316.0M) |
| Proceeds from sale of business | $0 | — | — | $3.9B |
| Other — net | $3.0M | $3.0M | $7.0M | ($12.0M) |
| Net cash (used in) provided by investing activities | ($244.0M) | ($164.0M) | ($77.0M) | $3.5B |
| Repayment of debt | $0 | $0 | $0 | ($3.0B) |
| Proceeds from debt, net of issuance costs | $46.0M | $46.0M | $46.0M | $0 |
| Net transfers from (to) 3M | $2.0M | $2.0M | $2.0M | ($21.0M) |
| Purchases of treasury stock | ($403.0M) | ($355.0M) | ($67.0M) | — |
| Other — net | ($46.0M) | ($44.0M) | ($31.0M) | $49.0M |
| Net cash used in financing activities | ($401.0M) | ($350.0M) | ($50.0M) | ($2.9B) |
| Effect of exchange rate changes on cash and cash equivalents | $1.0M | $1.0M | ($2.0M) | $6.0M |
| Net (decrease) increase in cash and cash equivalents | ($428.0M) | ($475.0M) | ($318.0M) | $880.0M |
| Cash and cash equivalents at beginning of period | $878.0M | $878.0M | $878.0M | $762.0M |
| Cash and cash equivalents at end of period | $451.0M | $403.0M | $561.0M | $1.6B |
| Right-of-use assets obtained in exchange for finance lease liability | $207.0M | $204.0M | $207.0M | — |
Solventum Corporation score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.